Our research on Pubmed Click here Steeve Boulant 3/31/25 Steeve Boulant 3/31/25 Rotavirus Spreads in a Spatially Controlled Manner Read More Steeve Boulant 3/31/25 Steeve Boulant 3/31/25 SARS-CoV-2 ORF 3a-mediated currents are inhibited by antiarrhythmic drugs Read More Steeve Boulant 3/31/25 Steeve Boulant 3/31/25 Interleukin-22 Promotes Cell Proliferation to Combat Virus Infection in Human Intestinal Epithelial Cells Read More Steeve Boulant 3/31/25 Steeve Boulant 3/31/25 The Role of Interleukin-22 in Controlling Virus Infections at Mucosal Surfaces Read More Steeve Boulant 3/31/25 Steeve Boulant 3/31/25 The population context is a driver of the heterogeneous response of epithelial cells to interferons Read More Steeve Boulant 3/31/25 Steeve Boulant 3/31/25 Glucosylceramide in bunyavirus particles is essential for virus binding to host cells Read More Steeve Boulant 3/31/25 Steeve Boulant 3/31/25 Differential signaling by type-I and type-III interferons in mucosa Read More Steeve Boulant 3/31/25 Steeve Boulant 3/31/25 Hypoxia and HIF-1α promote lytic de novo KSHV infection Read More Steeve Boulant 3/31/25 Steeve Boulant 3/31/25 Extended methods for spatial cell classification with DBSCAN-CellX Read More Steeve Boulant 3/31/25 Steeve Boulant 3/31/25 Transcriptomics-inferred dynamics of SARS-CoV-2 interactions with host epithelial cells Read More Steeve Boulant 3/31/25 Steeve Boulant 3/31/25 Regionalization of the antiviral response in the gastrointestinal tract to provide spatially controlled host/pathogen interactions Read More Steeve Boulant 3/31/25 Steeve Boulant 3/31/25 Virology under the Microscope-a Call for Rational Discourse Read More Steeve Boulant 3/31/25 Steeve Boulant 3/31/25 Protocol for SARS-CoV-2 infection of kidney organoids derived from human pluripotent stem cells Read More Steeve Boulant 3/31/25 Steeve Boulant 3/31/25 Type III interferons: Emerging roles beyond antiviral barrier defense Read More Steeve Boulant 3/31/25 Steeve Boulant 3/31/25 Type III and Not Type I Interferons Efficiently Prevent the Spread of Rotavirus in Human Intestinal Epithelial Cells Read More Steeve Boulant 3/31/25 Steeve Boulant 3/31/25 USP22 controls type III interferon signaling and SARS-CoV-2 infection through activation of STING Read More Steeve Boulant 3/31/25 Steeve Boulant 3/31/25 Genetic regulation of OAS1 nonsense-mediated decay underlies association with COVID-19 hospitalization in patients of European and African ancestries Read More Steeve Boulant 3/31/25 Steeve Boulant 3/31/25 A model for network-based identification and pharmacological targeting of aberrant, replication-permissive transcriptional programs induced by viral infection Read More Steeve Boulant 3/31/25 Steeve Boulant 3/31/25 A family of conserved bacterial virulence factors dampens interferon responses by blocking calcium signaling Read More Steeve Boulant 3/31/25 Steeve Boulant 3/31/25 A diabetic milieu increases ACE2 expression and cellular susceptibility to SARS-CoV-2 infections in human kidney organoids and patient cells Read More Older Posts
Steeve Boulant 3/31/25 Steeve Boulant 3/31/25 Rotavirus Spreads in a Spatially Controlled Manner Read More
Steeve Boulant 3/31/25 Steeve Boulant 3/31/25 SARS-CoV-2 ORF 3a-mediated currents are inhibited by antiarrhythmic drugs Read More
Steeve Boulant 3/31/25 Steeve Boulant 3/31/25 Interleukin-22 Promotes Cell Proliferation to Combat Virus Infection in Human Intestinal Epithelial Cells Read More
Steeve Boulant 3/31/25 Steeve Boulant 3/31/25 The Role of Interleukin-22 in Controlling Virus Infections at Mucosal Surfaces Read More
Steeve Boulant 3/31/25 Steeve Boulant 3/31/25 The population context is a driver of the heterogeneous response of epithelial cells to interferons Read More
Steeve Boulant 3/31/25 Steeve Boulant 3/31/25 Glucosylceramide in bunyavirus particles is essential for virus binding to host cells Read More
Steeve Boulant 3/31/25 Steeve Boulant 3/31/25 Differential signaling by type-I and type-III interferons in mucosa Read More
Steeve Boulant 3/31/25 Steeve Boulant 3/31/25 Hypoxia and HIF-1α promote lytic de novo KSHV infection Read More
Steeve Boulant 3/31/25 Steeve Boulant 3/31/25 Extended methods for spatial cell classification with DBSCAN-CellX Read More
Steeve Boulant 3/31/25 Steeve Boulant 3/31/25 Transcriptomics-inferred dynamics of SARS-CoV-2 interactions with host epithelial cells Read More
Steeve Boulant 3/31/25 Steeve Boulant 3/31/25 Regionalization of the antiviral response in the gastrointestinal tract to provide spatially controlled host/pathogen interactions Read More
Steeve Boulant 3/31/25 Steeve Boulant 3/31/25 Virology under the Microscope-a Call for Rational Discourse Read More
Steeve Boulant 3/31/25 Steeve Boulant 3/31/25 Protocol for SARS-CoV-2 infection of kidney organoids derived from human pluripotent stem cells Read More
Steeve Boulant 3/31/25 Steeve Boulant 3/31/25 Type III interferons: Emerging roles beyond antiviral barrier defense Read More
Steeve Boulant 3/31/25 Steeve Boulant 3/31/25 Type III and Not Type I Interferons Efficiently Prevent the Spread of Rotavirus in Human Intestinal Epithelial Cells Read More
Steeve Boulant 3/31/25 Steeve Boulant 3/31/25 USP22 controls type III interferon signaling and SARS-CoV-2 infection through activation of STING Read More
Steeve Boulant 3/31/25 Steeve Boulant 3/31/25 Genetic regulation of OAS1 nonsense-mediated decay underlies association with COVID-19 hospitalization in patients of European and African ancestries Read More
Steeve Boulant 3/31/25 Steeve Boulant 3/31/25 A model for network-based identification and pharmacological targeting of aberrant, replication-permissive transcriptional programs induced by viral infection Read More
Steeve Boulant 3/31/25 Steeve Boulant 3/31/25 A family of conserved bacterial virulence factors dampens interferon responses by blocking calcium signaling Read More
Steeve Boulant 3/31/25 Steeve Boulant 3/31/25 A diabetic milieu increases ACE2 expression and cellular susceptibility to SARS-CoV-2 infections in human kidney organoids and patient cells Read More
